Literature DB >> 8601560

Hereditary cancer: two hits revisited.

A G Knudson1.   

Abstract

According to a "two-hit" model, dominantly inherited predisposition to cancer entails a germline mutation, while tumorigenesis requires a second, somatic, mutation. Non-hereditary cancer of the same type requires the same two hits, but both are somatic. The original tumor used in this model, retinoblastoma, involves mutation or loss of both are somatic. The original tumor used in this model, retinoblastoma, involves mutation or loss of both copies of the RB1 tumor-suppressor gene in both hereditary and non-hereditary forms. In fact, most dominantly inherited cancers show this relationship. New dominantly inherited cancers show this relationship. New questions have arisen, however. When a tumor-suppressor gene is ubiquitously expressed, why is there any specificity of tumor predilection? In some instances, it is clear that two hits produce only a benign precursor lesion and that other genetic events are necessary. As the number of necessary events increase, the impact of the germline mutation diminishes. The number of events is least for embryonal tumors, and relatively small for certain sarcomas. Stem-cell proliferation evidently plays a key role early in carcinogenesis. In some tissues it is physiological, as in embryonic development and in certain tissues in adolescence. In adult renewal tissues, the sites of the common carcinomas, mutation may be necessary to impair the control of switching between renewal and replicative cell divisions; the APC gene may be the target of such a mutation.

Entities:  

Mesh:

Year:  1996        PMID: 8601560     DOI: 10.1007/bf01366952

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  58 in total

1.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Chromosomal deletion and retinoblastoma.

Authors:  A G Knudson; A T Meadows; W W Nichols; R Hill
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

Review 3.  The approaching era of the tumor suppressor genes.

Authors:  G Klein
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

4.  Sporadic bilateral retinoblastoma and 13q- chromosomal deletion.

Authors:  U Francke; F Kung
Journal:  Med Pediatr Oncol       Date:  1976

5.  Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

Authors:  D I Linzer; A J Levine
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

6.  Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14.

Authors:  R S Sparkes; M C Sparkes; M G Wilson; J W Towner; W Benedict; A L Murphree; J J Yunis
Journal:  Science       Date:  1980-05-30       Impact factor: 47.728

7.  Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.

Authors:  A Koufos; M F Hansen; B C Lampkin; M L Workman; N G Copeland; N A Jenkins; W K Cavenee
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

8.  Loss of a Harvey ras allele in sporadic Wilms' tumour.

Authors:  A E Reeve; P J Housiaux; R J Gardner; W E Chewings; R M Grindley; L J Millow
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

9.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

Authors:  W H Lee; R Bookstein; F Hong; L J Young; J Y Shew; E Y Lee
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

10.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  94 in total

Review 1.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.

Authors:  Junko Naito; Hiroshi Kaji; Hideaki Sowa; Riko Kitazawa; Sohei Kitazawa; Toshihiko Tsukada; Geoffrey N Hendy; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

3.  Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling.

Authors:  Caroline Bonnans; Maud Flacelière; Fanny Grillet; Christelle Dantec; Jean-Pierre Desvignes; Julie Pannequin; Dany Severac; Emeric Dubois; Frédéric Bibeau; Virginie Escriou; Philippe Crespy; Laurent Journot; Frédéric Hollande; Dominique Joubert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

4.  De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.

Authors:  Ajay Goel; Thuy-Phuong Nguyen; Hon-Chiu E Leung; Takeshi Nagasaka; Jennifer Rhees; Erin Hotchkiss; Mildred Arnold; Pia Banerji; Minoru Koi; Chau-To Kwok; Deborah Packham; Lara Lipton; C Richard Boland; Robyn L Ward; Megan P Hitchins
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

5.  Mutations in CIC and FUBP1 contribute to human oligodendroglioma.

Authors:  Chetan Bettegowda; Nishant Agrawal; Yuchen Jiao; Mark Sausen; Laura D Wood; Ralph H Hruban; Fausto J Rodriguez; Daniel P Cahill; Roger McLendon; Gregory Riggins; Victor E Velculescu; Sueli Mieko Oba-Shinjo; Suely Kazue Nagahashi Marie; Bert Vogelstein; Darell Bigner; Hai Yan; Nickolas Papadopoulos; Kenneth W Kinzler
Journal:  Science       Date:  2011-08-04       Impact factor: 47.728

6.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

7.  The epidemiology of prolactinomas.

Authors:  Antonio Ciccarelli; Adrian F Daly; Albert Beckers
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

8.  Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma.

Authors:  Yuwaraj Kadariya; Bu Yin; Baiqing Tang; Susan A Shinton; Eoin P Quinlivan; Xiang Hua; Andres Klein-Szanto; Tahseen I Al-Saleem; Craig H Bassing; Richard R Hardy; Warren D Kruger
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

9.  Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.

Authors:  Johan Kugelberg; Jenny Welander; Francesca Schiavi; Ambrogio Fassina; Martin Bäckdahl; Catharina Larsson; Giuseppe Opocher; Peter Söderkvist; Patricia L Dahia; Hartmut P H Neumann; Oliver Gimm
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

10.  High risk for neoplastic transformation of endometriosis in a carrier of Lynch syndrome.

Authors:  Christine Nyiraneza; Etienne Marbaix; Mireille Smets; Christine Galant; Christine Sempoux; Karin Dahan
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.